Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.
Rethinking iPSC Development: Why Adopting an Early CMC Strategy is Essential
Aug 13, 2025
Start with the End in Mind: Materials Control in Early CMC Strategy
Jul 31, 2025
Developing iPSC Therapies: Why Your CMC Strategy Needs to Start Early
Jul 15, 2025
eXmoor Pharma Strengthens Leadership Team with New CEO Appointment
Jul 8, 2025
Industry News
eXmoor Pharma and Signadori Bio launch partnership to develop next-generation monocyte-based cell therapy for solid tumours
Jun 17, 2025
Industry News
Scaling Gene Therapy Production: From Bench to Clinic
May 30, 2025
eXmoor Pharma and KU Leuven announce strategic partnership to accelerate cell and gene therapy innovation through new venture
May 13, 2025
Industry News
eXmoor Pharma Strengthens Board with Appointment of Dr James Miskin as Non-Executive Director
Apr 1, 2025
Industry News
eXmoor and Virica receive funding to improve AAV gene therapy manufacturing
Oct 17, 2024
Industry News